Mithra Pharmaceuticals SA (STU:1TM)
€ 0.18 0 (0%) Market Cap: 12.04 Mil Enterprise Value: 196.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Full Year 2020 Mithra Pharmaceuticals SA Earnings Call Transcript

Mar 09, 2021 / 08:30AM GMT
Release Date Price: €23.55 (+8.03%)
Operator

Hello, and welcome to the Mithra Full Year Results 2020 Conference Call with Mr. Leon Van Rompay, CEO; Mr. Christophe Maréchal, CFO; Mr. Graham Dixon, Chief Scientific Officer; Jean-Michel Foidart, VP, External and Scientific AF.

My name is Val, and I will be your coordinator for today's event. Please note, this conference is being recorded. (Operator Instructions)

I will now hand you over to your host Mr. Benoit Mathieu, Investor Relations, to begin today's conference. Thank you.

Benoit Mathieu
Mithra Pharmaceuticals SA - IR Officer

Thank you, Val. Welcome to Mithra's Full Year Results 2020. My name is Benoit Mathieu, Investor Relations Officer. I am joined in the room by Mr. Leon Van Rompay, our CEO; Mr. Christophe Maréchal, CFO; Mr. Graham Dixon, Chief Scientific Officer; and Mr. Jean-Michel Foidart, VP External and Scientific Affairs. This webcast is recorded and will be accessible on the Mithra homepage and will be available later today for replay.

I would like to remind you that this webcast is covered by the safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot